Sirolimus-coated balloons were noninferior to paclitaxel-coated balloons in terms of safety and efficacy in treating patients with femoropopliteal artery disease, based on findings from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback